How should China set ethical guardrails for medical research?

Journal of Medical Ethics 50 (11):744-748 (2024)
  Copy   BIBTEX

Abstract

‘Ethics first’ reform in China significantly changes the governance framework for the research of emerging technologies. The misapplication of human genome editing technology reflects the urgent need to reform the governance framework. Strengthening ethics governance in medical research has become a consensus in China, where legal and ethical reforms are proceeding in parallel. The protection of human dignity, the prevention of biosafety risks, as well as the regulation of technological crimes are at the core of the legal system, which has been embodied in numerous fundamental legislations following the CRISPR-babies incident. Establishing a national ethics committee to coordinate ethics governance, and reinforcing ethics review and external oversight are significant steps in ethical reform. Essentially, ethics governance requires implementing the basic concept of ‘ethics first’, focusing on forward-looking and preventive governance rather than delayed intervention, while maintaining openness and collaboration.

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 103,449

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Clinical governance—watchword or buzzword?Alastair V. Campbell - 2001 - Journal of Medical Ethics 27 (suppl 1):54-56.

Analytics

Added to PP
2023-12-20

Downloads
23 (#983,168)

6 months
7 (#469,699)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Citations of this work

Allowing for open debate in medical ethics.Cressida Auckland - 2024 - Journal of Medical Ethics 50 (11):723-724.

Add more citations

References found in this work

No references found.

Add more references